All Stories

  1. Simplified PCR-Based Quantification of Proteins with DNA Aptamers and Methylcellulose as a Blocking Agent
  2. Enhanced Membrane Fluidization and Cholesterol Displacement by 1-Heptanol Inhibit Mast Cell Effector Functions
  3. Simultaneous reduction of all ORMDL proteins decreases the threshold of mast cell activation
  4. Pentacyclic triterpenoid ursolic acid interferes with mast cell activation via a lipid-centric mechanism affecting FcεRI signalosome functions
  5. Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins
  6. ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling
  7. Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways
  8. Tetraspanins in the regulation of mast cell function
  9. Triacylglycerol‐Rich Oils of Marine Origin are Optimal Nutrients for Induction of Polyunsaturated Docosahexaenoic Acid Ester of Hydroxy Linoleic Acid (13‐DHAHLA) with Anti‐Inflammatory Properties in Mice
  10. Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells
  11. Carboxymethylcellulose enhances the production of single-stranded DNA aptamers generated by asymmetric PCR
  12. Mast Cell Migration and Chemotaxis Assayed by Microscopy
  13. The transmembrane adaptor protein NTAL limits mast cell chemotaxis toward prostaglandin E 2
  14. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein
  15. Changing the threshold-Signals and mechanisms of mast cell priming
  16. Positive and Negative Signals in Mast Cell Activation
  17. Tetraspanins and Transmembrane Adaptor Proteins As Plasma Membrane Organizers—Mast Cell Case
  18. Signal transduction and chemotaxis in mast cells
  19. Signal transduction imunoreceptors IgE
  20. New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling
  21. Ethanol Inhibits High-Affinity Immunoglobulin E Receptor (FcεRI) Signaling in Mast Cells by Suppressing the Function of FcεRI-Cholesterol Signalosome
  22. Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells
  23. Real-time PCR-based genotyping from whole blood using Taq DNA polymerase and a buffer supplemented with 1,2-propanediol and trehalose
  24. Transmembrane Adaptor Protein PAG/CBP Is Involved in both Positive and Negative Regulation of Mast Cell Signaling
  25. Membrane-Cytoskeleton Dynamics in the Course of Mast Cell Activation
  26. Molecular targets on mast cells and basophils for novel therapies
  27. Multiple Regulatory Roles of the Mouse Transmembrane Adaptor Protein NTAL in Gene Transcription and Mast Cell Physiology
  28. Gold nanoparticle-based immuno-PCR for detection of tau protein in cerebrospinal fluid
  29. Microscopy Assays for Evaluation of Mast Cell Migration and Chemotaxis
  30. Quantification of α-tubulin isotypes by sandwich ELISA with signal amplification through biotinyl-tyramide or immuno-PCR
  31. Cross-talk between Tetraspanin CD9 and Transmembrane Adaptor Protein Non-T Cell Activation Linker (NTAL) in Mast Cell Activation and Chemotaxis
  32. Fc receptor-γ subunits with both polar or non-polar amino acids at position of T22 are capable of restoring surface expression of the high-affinity IgE receptor and degranulation in γ subunit-deficient rat basophilic leukemia cells
  33. Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
  34. Novel Mechanism for FcϵRI-mediated Signal Transducer and Activator of Transcription 5 (STAT5) Tyrosine Phosphorylation and the Selective Influence of STAT5B over Mast Cell Cytokine Production
  35. Transmembrane Adaptor Proteins in the High-Affinity IgE Receptor Signaling
  36. Rapid and sensitive detection of cytokines using functionalized gold nanoparticle-based immuno-PCR, comparison with immuno-PCR and ELISA
  37. 1,2-propanediol-trehalose mixture as a potent quantitative real-time PCR enhancer
  38. STIM1-Directed Reorganization of Microtubules in Activated Mast Cells
  39. The transmembrane adaptor protein NTAL signals to mast cell cytoskeleton via the small GTPase Rho
  40. What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen‐activated mast cell?
  41. Down-regulation of Protein-tyrosine Phosphatases Activates an Immune Receptor in the Absence of Its Translocation into Lipid Rafts
  42. Vacuolin-1-modulated exocytosis and cell resealing in mast cells
  43. Engagement of Phospholipid Scramblase 1 in Activated Cells
  44. Topography of signaling molecules as detected by electron microscopy on plasma membrane sheets isolated from non-adherent mast cells
  45. Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes
  46. Regulation of Ca2+ Signaling in Mast Cells by Tyrosine-Phosphorylated and Unphosphorylated Non-T Cell Activation Linker
  47. Non-apoptotic Phosphatidylserine Externalization Induced by Engagement of Glycosylphosphatidylinositol-anchored Proteins
  48. Changes in GM1 ganglioside content and localization in cholestatic rat liver
  49. Topography of plasma membrane microdomains and its consequences for mast cell signaling
  50. Regulation of Microtubule Formation in Activated Mast Cells by Complexes of γ-Tubulin with Fyn and Syk Kinases
  51. Lifting the fog in store-operated Ca2+ entry
  52. Regulation of Cys-Based Protein Tyrosine Phosphatases Via Reactive Oxygen and Nitrogen Species in Mast Cells and Basophils
  53. Negative Regulation of Mast Cell Signaling and Function by the Adaptor LAB/NTAL
  54. Signaling assemblies formed in mast cells activated via Fcϵ receptor I dimers
  55. NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc RI aggregation
  56. Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases
  57. Involvement of filamentous actin in setting the threshold for degranulation in mast cells
  58. Positive and negative regulation of Fcϵ receptor I‐mediated signaling events by Lyn kinase C‐terminal tyrosine phosphorylation
  59. One-tube semi-nested PCR-ELISA for the detection of human cytomegalovirus DNA sequences; comparison with hybridization-based and semi-nested-based PCR-ELISA procedures
  60. Exogenous Administration of Gangliosides Inhibits FcεRI-Mediated Mast Cell Degranulation by Decreasing the Activity of Phospholipase Cγ
  61. A role of tyrosine kinase Syk during neuronal differentiation of raurine embryonal carcinoma cells P19, stimulated by retinoic acid
  62. Non–T Cell Activation Linker (NTAL)
  63. Lipid rafts in mast cell signaling
  64. A novel lipid raft-associated glycoprotein, TEC-21, activates rat basophilic leukemia cells independently of the type 1 Fcε receptor
  65. Nonreceptor Protein Tyrosine and Lipid Phosphatases in Type I Fcε Receptor-Mediated Activation of Mast Cells and Basophils
  66. Structure-Function Analysis of Lyn Kinase Association with Lipid Rafts and Initiation of Early Signaling Events after Fcɛ Receptor I Aggregation
  67. Carcinoembryonic antigen-related cell adhesion molecule 1 is the 85-kilodalton pronase-resistant biliary glycoprotein in the cholesterol crystallization promoting low density protein-lipid complex
  68. Lipid Rafts and Their Role in Signal Transduction-Mast Cells as a Model
  69. Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3‐fucosyl‐N‐acetyl‐lactosamine moiety
  70. The Specificity for the Differentiation Blocking Activity of Carcinoembryonic Antigen Resides in Its Glycophosphatidyl-Inositol Anchor
  71. New specificity and yield enhancer of polymerase chain reactions
  72. Protein tyrosine kinase p53/p56lyn forms complexes with γ-tubulin in rat basophilic leukemia cells
  73. Redefined Nomenclature for Members of the Carcinoembryonic Antigen Family
  74. Comparison of the expression of specific cell surface epitopes on in vitro fertilized and parthenogenetic bovine embryos
  75. Requirement for a Negative Charge at Threonine 60 of the FcRγ for Complete Activation of Syk
  76. Cytochemical localization of GalNAc and GalNAcβ1,4Galβ1,4 disaccharide in mouse zona pellucida
  77. Functional heterogeneity of Thy-1 membrane microdomains in rat basophilic leukemia cells
  78. Lex glycosphingolipids-mediated cell aggregation
  79. The stage-specific expression of TEC-1, -2, -3, and -4 antigens on bovine preimplantation embryos
  80. Protein tyrosine kinase Syk is involved in Thy‐1 signaling in rat basophilic leukemia cells
  81. Inhibition of murine macrophage nitric oxide synthase expression by a pivoxil prodrug of antiviral acyclic nucleotide analogue 9-(2-phosphonomethoxyethyl)adenine
  82. Src family‐selective tyrosine kinase inhibitor, PP1, inhibits both FcεRI‐ and Thy‐1‐mediated activation of rat basophilic leukemia cells
  83. Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fcε receptors
  84. Carbohydrate-Mediated Sorting in Aggregating Embryonal Carcinoma Cells
  85. Characterization of Fcγ receptors on rat mucosal mast cells using a mutant FcϵRI‐deficient rat basophilic leukemia line
  86. Thy‐1‐mediated activation of rat basophilic leukemia cells does not require co‐expression of the high‐affinity IgE receptor
  87. Aggregation of Thy-1 Glycoprotein Induces Tyrosine Phosphorylation of Different Proteins in Isolated Rat Mast Cells and Rat Basophilic Leukemia Cells
  88. Retinoic acid‐induced changes in differentiation‐defective embryonal carcinoma RAC65 cells
  89. Inhibition of fertilization by a monoclonal antibody recognizing the oligosaccharide sequence Ga1NAcβ1→4Ga1β1→4 on the mouse zona pellucida
  90. Functional expression of the endogenous Thy‐1 gene and the transfected murine Thy‐1.2 gene in rat basophilic leukemia cells
  91. Expression of Developmentally Regulated Genes in Embryonal Carcinoma Cells
  92. Unusual stage-specific embryonic antigen (TEC-4) defined by a monoclonal antibody to embryonal carcinoma cells defective in the expression of embryoglycan.
  93. Inhibition of adhesion of F9 embryonal carcinoma cells to substratum by a novel monoclonal antibody, TEC-05, reactive with a developmentally regulated carbohydrate epitope
  94. Expression of mouse embryonic epitope TEC-2 on human carcinoma-derived cell lines and characterization of its glycoprotein carriers
  95. Differential expression of mouse embryonic antigens TEC-1 and TEC-2 in the epididymis of four rodent species
  96. Mutants of embryonal carcinoma cells defective in the expression of embryoglycan.
  97. The epitope of mouse embryonic antigen(s) recognized by monoclonal antibody TEC-02 is a carbohydrate carried by high-molecular-weight glycoconjugates
  98. Developmentally regulated surface structures of teratocarcinoma stem cells studied by mutant cell lines
  99. Differentiation antigens of mouse teratocarcinoma stem cells defined by monoclonal antibodies
  100. Localization of mouse TEC-1,2,3 antigens in adult and fetal tissues in the rat and human
  101. Relationship of F9 antigens to spermatogenic cell antigens
  102. Cytotoxicity of plant lectins for mouse embryonal carcinoma cells
  103. Isolation and partial characterization of lectin-resistant F9 cells
  104. Autoimmune damage to spermatogenesis in rodents immunized with mouse F9 embryonic carcinoma cells.
  105. Mechanism of the inhibitory effect of hydrocortisone on concanavalin A-induced activation of thymus cells. Role of interleukins
  106. Biological activity of hormonally active and non-active androgen derivatives
  107. Expression of T-cell differentiation antigens on activated thymocytes
  108. Identification and characterization of immature thymocytes responsive to T cell growth factor
  109. ADDITION OF SERUM TO THE MEDIUM USED FOR PREPARATION OF CELL SUSPENSIONS AS A POSSIBLE SOURCE OF ARTIFACTS IN CELL‐MEDIATED REACTIONS STUDIED BY MEANS OF THE POPLITEAL LYMPH NODE TEST
  110. ESTABLISHMENT AND CHARACTERIZATION OF PERMANENT MURINE HYBRIDOMAS SECRETING MONOCLONAL ANTI‐THY‐1 ANTIBODIES *
  111. Identification of TL+ thymocytes with different Lyt phenotypes
  112. Cytochalasin B-induced changes in concanavalin A-activated lymphocytes
  113. ROLE OF CELL‐CELL INTERACTIONS IN MITOGENIC STIMULATION OF LYMPHOCYTES: I. DISSOCIATION OF CONCANAVALIN A‐INDUCIBLE LYMPHOCYTE ACTIVATION AND AGGLUTINATION